Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Crystal
Crystal Figlietti, Colma, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100092108 | ECO-FRIENDLY FOOD CONTAINER - A reusable, easily washable, eco-friendly food container that contains an enclosed pouch and a placemat. The eco-friendly food container folds over itself for spill free storage and in its open position is capable of wrapping around a horizontal bar to hang open so the pouch contents are easily accessible. A removable pouch tray facilitates food handling inside and outside of the pouch. | 04-15-2010 |
Crystal Gembala, Deerfield Beach, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20100313790 | Lightweight concrete composition containing soybean protein as a eco-friendly foaming agent - A lightweight composition is formed by combining and mixing Portland cement or other cementitous material with foam in order to create air pockets throughout the cementitious material. A foaming agent containing primarily or entirely soybean protein in liquid form is introduced with a pressurized flow of air and water in order to produce the foam. | 12-16-2010 |
Crystal Icenhour, Charlottesville, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20110020813 | ADVANCED PATHOGEN DETECTION AND SCREENING - Disclosed is a rapid, dual purpose, PCR-based method for identifying two or more pathogens, including | 01-27-2011 |
Crystal Mackall, Silver Spring, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090117116 | IMMUNOGENIC PEPTIDES AND METHODS OF USE FOR TREATING AND PREVENTING CANCER - Disclosed are immunogenic peptides, related fusion proteins, nucleic acids encoding the peptides or fusion proteins, conjugates, expression vectors, host cells, and antibodies. Also, disclosed are pharmaceutical compositions, vaccines for use in the treatment or prevention of cancer, e.g., alveolar rhabodomyosarcoma, methods of stimulating a T cell to kill a tumor cell, methods of stimulating CD4 | 05-07-2009 |
| 20110081352 | IMMUNOGENIC PEPTIDES AND METHODS OF USE FOR TREATING AND PREVENTING CANCER - Disclosed are immunogenic peptides, related fusion proteins, nucleic acids encoding the peptides or fusion proteins, conjugates, expression vectors, host cells, and antibodies. Also, disclosed are pharmaceutical compositions, vaccines for use in the treatment or prevention of cancer, e.g., alveolar rhabodomyosarcoma, methods of stimulating a T cell to kill a tumor cell, methods of stimulating CD4 | 04-07-2011 |
Crystal Mitcheltree, Paris, KY US
| Patent application number | Description | Published |
|---|---|---|
| 20110209701 | Nose pad cushion and applicator for respiratory mask - A removable nose pad cushion adherable to a medical face mask and more particularly to a positive pressure ventilation mask approximately where the mask rests on the upper nose area of a wearer's face providing a cushioning seal between the mask and wearer's nose. The nose pad cushion can be impregnated with medication to be adsorbed by the skin of the patient. The surface of the nose pad cushion which contacts the skin of the user is soft and pliable and selected to removably adhere only to dry skin and is incapable of sticking to a moist wound bed or sores formed on the bridge of the nose. The area covered by the cushion primarily covers the upper nose area but could cover the entire interface between the mask and the face of a user. The cushion can be pre-shaped to be applied to the desired area of the mask. The adhesive which holds the cushion to the mask is of a type such that the cushion can be removed cleanly and replaced with another cushion periodically. | 09-01-2011 |
Crystal Pollock-Dove, Mountain View, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100247632 | STABILIZED SOLUBILITY-ENHANCED FORMULATIONS FOR ORAL DELIVERY - Methods and compositions are described whereby poorly water-soluble beneficial agents such as vitamins and co-factors are formulated into self-emulsifying formulas (SEF) and optionally sorbing the SEF into pores of porous solid particulates, or preparing supersaturated solutions (SSS) and sorbing the SSS into pores of porous solid particulates. These formulations are useful as dosage forms with oral availability. | 09-30-2010 |
Crystal Wang, La Palma, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090004107 | BETA-AMYLOID AND NEUROFIBRILLARY TANGLE IMAGING AGENTS - Compounds, compositions and methods are contemplated in which senile plaques and/or neurofibrillary tangles are labeled using compounds with improved permeability across the blood brain barrier and improved selective binding to senile plaques and/or neurofibrillary tangles. Contemplated compounds are derivatives of FDDNP or curcumin, which most preferably have improved solubility in aqueous solvents. Labeling is typically performed using a PET detectable label, and especially | 01-01-2009 |
Crystal Zellofrow, Apollo, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100273722 | MODIFIED MINIATURE PROTEINS - The present invention generally relates to modified miniature proteins, including modified avian pancreatic polypeptides (aPP) and modified pancreatic peptide YYs (PYY). One aspect of the invention is generally directed to various aPPs that have been modified such that they do not substantially form multimers in solution, for example through the addition of a proline switch. Another aspect of the invention is generally directed to modified PYYs, such as YY3. Yet another aspect of the invention is generally directed to composites of modified miniature proteins formed from portions of different miniature proteins such as aPP and/or PYY, optionally with a proline switch. Still other aspects of the invention are generally directed to methods of making such proteins, methods of using such proteins, kits involving such proteins, and the like. | 10-28-2010 |